Ari Nowacek

738 citations
14 papers · 577 indexed · h-index 10
Topics
HIV Research and Treatment (7 papers)Nanoparticle-Based Drug Delivery (3 papers)HIV/AIDS Research and Interventions (3 papers)
Partner nations
United States

In The Last Decade

Ari Nowacek

14 papers receiving 571 citations

Peers

Ari Nowacek
Comparison fields: 5 of 76
  • Virology 263
  • Infectious Diseases 206
  • Molecular Biology 150
  • Pharmaceutical Science 103
  • Biomaterials 97
Replace Jane Werling with:
Jane Werling United States
Aditya N. Bade United States
Lipa Shah United States
Edward Makarov United States
Shahriar Pooyan United States
Trevor Castor United States
Sipho Mdanda South Africa
Kathryn A. Shelton United States
Priyanka Arora United States
Alan Smith United States
Ari Nowacek relative to Jane Werling United States Jane Werling's profile →
Citations per field
00.5×1.5×
Jane Werling · 1×
Citations per year

Countries citing papers authored by Ari Nowacek

Since Specialization
Citations

This map shows the geographic impact of Ari Nowacek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Nowacek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Nowacek more than expected).

Fields of papers citing papers by Ari Nowacek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ari Nowacek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Nowacek. The network helps show where Ari Nowacek may publish in the future.

Co-authorship network of co-authors of Ari Nowacek

This figure shows the co-authorship network connecting the top 25 collaborators of Ari Nowacek. A scholar is included among the top collaborators of Ari Nowacek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ari Nowacek. Ari Nowacek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 23
2 1
3 6
4 5
5 54
6 4
7 91
8 15
9 25
10 83
11 102
12 48
13 101
14 19

About Ari Nowacek

Ari Nowacek is a scholar working on Virology, Pharmaceutical Science and Developmental Neuroscience, having authored 14 papers that have together received 577 indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), Nanoparticle-Based Drug Delivery (3 papers) and HIV/AIDS Research and Interventions (3 papers). The work is most often cited by research in Virology (263 citations), Pharmaceutical Science (103 citations) and Infectious Diseases (206 citations). Ari Nowacek has collaborated with scholars based in United States. Frequent co-authors include Howard E. Gendelman, JoEllyn McMillan, Barrett Rabinow, JoEllyn McMillan, Reagan L. Miller, Georgette D. Kanmogne, R. Lee Mosley, Lisa M. Kosloski, Irena Kadiu and Shantanu Balkundi. Their work appears in journals such as Clinical Cancer Research, Journal of Controlled Release and American Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026